Eterna Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eterna Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Eterna Therapeutics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$4.93M, a 8.4% decline year-over-year.
  • Eterna Therapeutics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$22M, a 4.01% increase year-over-year.
  • Eterna Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$21.1M, a 36.4% increase from 2022.
  • Eterna Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$33.2M, a 70.8% increase from 2021.
  • Eterna Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$114M, a 1469% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$22M -$4.93M -$382K -8.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$21.6M -$5.79M -$471K -8.86% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$21.1M -$5.77M -$1.03M -21.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$20.1M -$5.51M +$2.8M +33.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$22.9M -$4.55M +$9.33M +67.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$32.2M -$5.32M +$980K +15.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$33.2M -$4.74M +$3.79M +44.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$37M -$8.3M +$78M +90.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$115M -$13.9M -$3.87M -38.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$111M -$6.3M +$2.63M +29.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$114M -$8.52M -$6.32M -286% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$107M -$86.3M -$84.3M -4198% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$23.1M -$10M -$7.99M -396% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$15.2M -$8.92M -$7.91M -779% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-01
Q4 2020 -$7.25M -$2.21M -$980K -79.8% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 -$6.27M -$2.01M -$1.69M -535% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.58M -$2.02M -$2.02M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$2.56M -$1.01M -$798K -368% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$1.76M -$1.23M -$1.4M -809% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$362K -$316K -$686K -185% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $324K -$2K* +$25K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $299K -$217K +$96K +30.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
Q4 2018 $203K $173K +$662K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$459K $370K +$423K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 -$882K -$27K -$1K -3.85% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$881K -$313K +$521K +62.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$1.4M -$489K -$189K -63% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$1.21M -$53K +$361K +87.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$1.57M -$26K +$670K +96.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$2.24M -$834K +$34K +3.92% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$2.28M -$300K +$603K +66.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$2.88M -$414K +$900K +68.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$3.78M -$696K +$1.78M +71.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$5.56M -$868K +$1.34M +60.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$6.9M -$903K +$610K +40.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 -$7.51M -$1.31M -$39K -3.06% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$7.47M -$2.47M -$1.17M -90.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$6.29M -$2.21M -$1.55M -237% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.74M -$1.51M -$1.11M -276% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$3.63M -$1.28M -$1.04M -440% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$2.59M -$1.3M -$1.19M -1030% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$1.41M -$654K -$288K -78.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$1.12M -$402K -$881K -184% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$238K -$236K -$335K -338% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $97K -$115K +$528K +82.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$431K -$366K +$631K +63.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$1.06M $479K +$1.39M Oct 1, 2012 Dec 31, 2012 10-K 2013-03-29
Q3 2012 -$2.45M $99K +$894K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.34M -$643K +$410K +38.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$3.75M -$997K -$477K -91.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$3.28M -$908K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$795K -$950K -613% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-29
Q2 2011 -$1.05M -$646K -159% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-29
Q1 2011 -$520K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-29
Q3 2010 $155K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$407K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.